Maxonis is a biotech start-up developing LDP-916, a novel peptide embedded in an injectable hydrogel designed to regenerate damaged nerves.
Backed by over 15 years of academic research and a strong IP portfolio, LDP-916 provides a safe, scalable solution for injuries to the peripheral and central nervous systems.
Our mission is to restore hope and function to individuals whose lives have been disrupted by nerve damage.
We collaborate closely with clinicians to bring cutting-edge innovation into real-world care – transforming outcomes, one nerve at a time.
Company Details
- Employees
- 11
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.maxonis.com
- Keywords
- Tel Aviv.
Maxonis Questions
Maxonis's website is http://www.maxonis.com
Maxonis's LinkedIn profile is https://www.linkedin.com/company/maxonis
Maxonis has
11 employees.
View email and phone details for 11
employees at Maxonis.
Maxonis's industry is
Biotechnology Research
Maxonis's top competitors are
Proximo,
Btg A Ferring Company,
Cashhero.ai,
Pulse 63 Healthcare Ventures,
O’taste,
Meatologic,
Hrbiz,
Totsaot - Human Resources,
Baibys™ Fertility,
Applicaster.
Maxonis's categories are Biotechnology Research
Maxonis's founding year is 2022
